Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
极光大麻 | 6-K：外国发行人报告（业绩相关）
Moomoo AI 已提取核心信息
Aurora Cannabis Inc. reported strong financial results for Q4 and fiscal year 2024, with record annual adjusted EBITDA of $12.8 million. Q4 net revenue increased 5% YoY to $67.4 million, driven by 20% growth in global medical cannabis revenue to $45.6 million. The company achieved its sixth consecutive quarter of positive adjusted EBITDA.Aurora ended the fiscal year with a cash position of ~$180 million and a debt-free cannabis business. The company reaffirmed its target of reaching positive free cash flow by December 31, 2024. CEO Miguel Martin highlighted Aurora's leadership in the global medical cannabis market and strong growth in key European markets.For Q1 2025, Aurora expects mid to high teens percentage growth in consolidated net revenue, driven by international medical cannabis expansion and seasonal strength in plant propagation. The company anticipates higher adjusted EBITDA and improved operating cash flow compared to Q4 2024.